Help Shape the Future of Pharmacogenetic Policy in Canada

Summary

Researchers at the University of Calgary are studying how pharmacogenetic (PGx) testing policies are being developed and used in Canada to support mental health care for children and young people.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 60

Accepts healthy participants: Yes

Inclusion criteria:

Who can participate?
Individuals who work in:
• Health-policy development or government roles
• Clinical leadership or service delivery
• Genomics or pharmacogenetics research
• Ethics, legal, or health-equity organizations
• Community or patient-advocacy groups

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Interested? Contact: Prosper Mandela Awuni | University of Calgary

Principal investigator:

Jennifer Zwicker

Clinical trial:

No

REB-ID:

REB25-1786